Redcare Pharmacy's Q1 sales rose 28% and company reiterates full-year 2025 outlook

From Nasdaq: 2025-05-06 02:02:00

Redcare Pharmacy N.V. (SAE1.F) reported higher first-quarter revenues, with sales reaching 717 million euros, up from 560 million euros last year. Sales in the DACH segment rose 28.5% to 583 million euros, while the international segment saw a 26.2% increase to 135 million euros. EBITDA declined to 7.7 million euros, with adjusted EBITDA at 9.1 million euros. The company reaffirmed its full-year 2025 outlook of total sales growth exceeding 25% and total adjusted EBITDA margin in the range of 2% to 2.5%. Redcare Pharmacy also expects mid- to longer-term adjusted EBITDA margin to be higher than 8%.



Read more at Nasdaq: Redcare Pharmacy Q1 Sales Rise 28%; Reiterates FY25 Outlook